SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Imclone systems (IMCL)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
2515 89 0 IMCL
Emcee:  Deeber Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2165Another good example of lawyer morality!613-3/4/2002
2164Thank you and Conciato for your responses to burden of proof issue. I agree thaZirdu-3/4/2002
2163Concaito-- The probability standard that I mentioned of one of 20 by chance doFred Levine-3/4/2002
2162The analogy is not mine, it is used by many epidemiologists/statisticians while Cacaito-3/3/2002
2161IMO, the analogy with a criminal trial is erroneous for the reasons that you staFred Levine-3/3/2002
2160Why in the world should drug companies have to prove effectiveness "beyond Zirdu-3/3/2002
2159Nigel, I think ELN at this point has far less downside, and it's a more probJim@Inland-3/3/2002
2158IRJ, Will You send an innocent man to jail, just because there is not a culprit Cacaito-3/2/2002
2157From interview of the Biotech industry association: "Do you think biotechCacaito-3/2/2002
2156As a LT Imclone holder, I am in complete agreement with Cacaito's position oFred Levine-3/2/2002
2155IJF, the classic personal "would you take it" when a drug is being evaCacaito-3/1/2002
2154You stated your positionm very well. However, I don't happen to agree with ytelephonics-3/1/2002
2153Cacaito, You said, "I do not believe Imcl clinical work at all" If yIRWIN JAMES FRANKEL-3/1/2002
2152<i>Good time for the ones that want to cut losses or keep gains!</i>nigel bates-3/1/2002
2151Few cancers are as untretable as H+N, but no one will go with Imcl as before witCacaito-3/1/2002
2150>>I would not expect the valuation to be the same as previous peak, unlesskeokalani'nui-3/1/2002
2149Today is probably a lot of short covering due to yesterdays gains. We'll ha613-3/1/2002
2148yes, a year late and billion$ short: If it is proven efficacious to reduce tumoCacaito-3/1/2002
2147So then it is pretty reasonable to assume that if it is at all eficacious, it wi613-3/1/2002
2146The MerckKG is evaluating tumor shrinkage, not survival, but it could be extendeCacaito-3/1/2002
2145Do you know if the Merck data is a full double blind study? Did the FDA agree 613-3/1/2002
2144Thanks, Wilder. Be well. The FoxThe Fox-2/28/2002
2143Bristol-Myers Squibb Shows Strong Commitment to ... ...Virology R&D at Top HCacaito-2/28/2002
2142Not at all, EU and US regulated trials are in constant communication with one anCacaito-2/28/2002
2141Isn't it unusual for the FDA to accept European trial data?613-2/28/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News